Study Evaluating Effexor XR for Major Depression.
Study Evaluating Effexor XR for Major Depression...
Brief Summary
Official Title: “Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression”
Study Evaluating Effexor XR for Major Depression.
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Intervention(s) in this Clinical Trial
- Drug: Effexor XR
- Drug: Milnacipran
Outcome Measures for this Clinical Trial
Primary Measures
- Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy.
Secondary Measures
- Difference of total score of HAM-D17 between baseline and final-on-therapy.
- Remission rate of HAM-D17 at the final-on-therapy.
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients diagnosed with major depression based on DSM-IV-TR
- Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" at the baseline.
Exclusion Criteria:
- Patients with schizophrenia or any other psychotic disorder
- Patients with history or presence of bipolar disorder
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 20 Years
Maximum Age for this Clinical Trial: 64 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Wyeth is now a wholly owned subsidiary of Pfizer Industry
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Wyeth is now a wholly owned subsidiary of Pfizer
Additional Information
Information obtained from ClinicalTrials.gov on February 08, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00225511
Study ID Number: 0600B1-816
ClinicalTrials.gov Identifier: NCT00225511
Health Authority: Japan: Pharmaceuticals and Medical Devices Agency
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00225511
